Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $862.1 | SEC | |
| Buy | $555.9 | SEC | |
| Buy | $556 | SEC | |
| Buy | $844 | SEC | |
| Buy | $555.4 | SEC | |
| Buy | $555.5 | SEC | |
| Buy | $826 | SEC | |
| Buy | $555.5 | SEC | |
| Buy | $555.5 | SEC | |
| Buy | $807.2 | SEC | |
| Buy | $555.7 | SEC | |
| AwardD | — | SEC | |
| Exercise | — | SEC | |
| Other | $741.4K | SEC | |
| ExerciseD | — | SEC | |
| Buy | $555.5 | SEC | |
| Buy | $779.2 | SEC | |
| Buy | $555.9 | SEC | |
| Buy | $555.6 | SEC | |
| Buy | $760.6 | SEC | |
| Buy | $555.9 | SEC | |
| Buy | $555.9 | SEC | |
| Buy | $741.3 | SEC | |
| Buy | $555.5 | SEC | |
| Buy | $555.8 | SEC |